SEC Form 4 · accession 0001209191-15-029973
CUMBERLAND PHARMACEUTICALS INC · CPIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
A J Kazimi
Officer — Chairman and CEO · Director · 10% Owner
Period of report
Mar 27, 2015
Accepted (ET)
Mar 27, 2015 · 5:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001087294
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 27, 2015 | A | 100,000 | $6.86 | A | 5,739,342 | D | |
| Common StockF2 | Mar 27, 2015 | F | 6,838 | $6.88 | D | 5,732,504 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted stock award will vest 100% on March 17, 2019.
- F2This transaction represents shares withheld by the Company to cover the tax withholding obligations for the vesting of 25,000 shares during March 2015.